Surgical Treatment of Irreducible Atlantoaxial Dislocation
Recruiting now · Not applicable
Conditions studied: Irreducible Atlantoaxial Dislocation
In brief
At present, there is a lack of standardized, large-scale, and high-level evidence-based medicine research on the safety and effectiveness of treatment of irreducible atlantoaxial dislocation (IAAD).Based on this, the goal of this prospective randomized controlled study is to systematically investigate the optimal surgical approach (simple posterior approach and the combined anterior and posterior approach) for managing IAAD, providing insights into the most efficacious and safest course of action. And long-term follow-up will be conducted on patients to evaluate the safety and effectiveness of different surgical methods, and to develop diagnostic and treatment standards for irreducible atlantoaxial dislocation.
Key facts
- Study ID
- NCT05847270
- Run by
- Peking University Third Hospital
- People needed
- 70
- Starts
- 2023-07-11
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2024-01-08
Who can join
Age: any, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Eligible participants encompass individuals within the age range of 0 to 80 years, without regard to gender.
- Patients who have received a diagnosis of irreducible atlantoaxial dislocation (IAAD) based on preoperative imaging and skull traction evaluation, with a traction weight equivalent to 1/6 of their body weight following anesthesia. These patients are candidates for surgical intervention.
- Participants who have provided informed consent either in person or through their legal representative (the principal).
You may not qualify if…
- Individuals with concomitant medical conditions or diseases that significantly impact surgical treatment, such as malignant metastasis or infectious diseases, will be excluded from the study.
- Critically ill patients, who are not suitable candidates for surgical intervention, will also be excluded.
- Patients who actively decline to participate in this research project will not be included in the study cohort.
Where it is running
- Peking University Third Hospital — Beijing, Beijing Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.